Bone Biologics Corporation
BBLGNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $696.42K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.39$2.76
- Volume (live)
- -
- Avg. volume (3M)
- 215.96K
Bone Biologics (BBLG) Stock Price & Financial Analysis
Bone Biologics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.39 - $0.41 |
|---|---|
| 52-Week High | $2.76 |
| 52-Week Low | $0.39 |
| Open | $0.41 |
| Volume (last close) | 59.74K |
| Average Volume (3M) | 215.96K |
| 50-Day MA | $0.58 |
|---|---|
| 200-Day MA | $1.13 |
| 1-Year Change | −84.37% |
| Market Cap | 696.42K |
|---|---|
| Shares Outstanding | 1.80M |
| Price to Book (P/B) | 0.18 |
| EV/EBITDA | 1.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Bone Biologics at a Glance
As of the Oct 16, 2026 close, Bone Biologics (BBLG) has a market capitalization of $696.42K.
As of its latest reported balance sheet, it holds $4.03M in cash and securities against $0.00 of debt, a net cash position of $4.03M.
Bone Biologics does not currently pay a dividend.
The share price is down 84.4% over the past year. At $0.40 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.39 to $2.76, below its 200-day moving average of $1.13.
Frequently Asked Questions About Bone Biologics
What is the current stock price for BBLG?
As of the Oct 16, 2026 close, BBLG stock trades at $0.40. The 52-week range is $0.39–$2.76, with a day range of $0.39–$0.41.
What is the P/E ratio for BBLG?
The P/E ratio (Price-to-Earnings) for BBLG is shown in the Key Statistics section. This valuation metric helps compare Bone Biologics Corporation to industry peers.
Does BBLG pay dividends?
Bone Biologics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BBLG?
Analyst ratings and recommendations for BBLG are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BBLG?
As of the Oct 16, 2026 close, Bone Biologics's market capitalization is $709,718.225, classifying it as a micro-cap company. Bone Biologics operates in the Healthcare sector within the Biotechnology industry.